Characteristics and outcomes of patients undergoing transcatheter mitral valve replacement with the Tendyne system.
Nihal WildeTetsu TenakaVivian VijAtsushi SugiuraMitsumasa SudoEva EichelerMiriam SilaschiJohanna VogelhuberFarhad BakhtiaryGeorg NickenigMarcel WeberSebastian ZimmerPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)
Among patients eligible for the Tendyne system, approximately a quarter of the patients underwent TMVR with the Tendyne system, which led substantial reduction of MR and LV reverse remodeling than TEER. In contrast, the 30-day mortality rate was higher after TMVR with the Tendyne compared to TEER.
Keyphrases
- mitral valve
- patients undergoing
- end stage renal disease
- ejection fraction
- magnetic resonance
- chronic kidney disease
- newly diagnosed
- prognostic factors
- type diabetes
- heart failure
- contrast enhanced
- risk factors
- magnetic resonance imaging
- cardiovascular disease
- metabolic syndrome
- patient reported outcomes
- left atrial
- atrial fibrillation